The Patrick Wild Centre is currently running the RECONNECT clinical trial for children and adolescents with fragile X syndrome.

The link below will take you to a website with more information about the trial and a place to enter your details if you are thinking of participating.  Or feel free to just contact us directly at pwcresearch@ed.ac.uk

Learn more about a clinical trial evaluating investigational topical cannabidiol (CBD) gel to see if it helps behavioural issues related to Fragile X syndrome.

Potential participants need to be:

• Between 3 and 17 years of age
• Diagnosed via genetic testing, with Fragile X syndrome
• In generally good health

Follow the link to find out more: Reconnect Fragile X Syndrome Research Study in UK | Zynerba (fragilexhelp.co.uk)